InMed Pharmaceuticals, Inc. (INM)
1.43
-0.03
(-2.05%)
USD |
NASDAQ |
Aug 24, 16:00
1.44
+0.01
(+0.70%)
After-Hours: 20:00
InMed Pharmaceuticals Enterprise Value : -0.0413M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | -0.0413M |
| August 21, 2026 | 0.0581M |
| August 20, 2026 | 0.4558M |
| August 19, 2026 | 0.4889M |
| August 18, 2026 | -0.0082M |
| August 17, 2026 | 0.0581M |
| August 14, 2026 | 0.0912M |
| August 13, 2026 | -0.0413M |
| August 12, 2026 | -0.0082M |
| August 11, 2026 | 0.0581M |
| August 10, 2026 | -0.1076M |
| August 07, 2026 | 0.0912M |
| August 06, 2026 | -0.0413M |
| August 05, 2026 | -0.1408M |
| August 04, 2026 | 0.1575M |
| August 03, 2026 | 0.0581M |
| July 31, 2026 | 0.0912M |
| July 30, 2026 | 0.1907M |
| July 29, 2026 | 0.754M |
| July 28, 2026 | 0.754M |
| July 27, 2026 | 0.6546M |
| July 24, 2026 | 0.8866M |
| July 23, 2026 | 1.351M |
| July 22, 2026 | 0.7209M |
| July 21, 2026 | 0.3232M |
| Date | Value |
|---|---|
| July 20, 2026 | 0.2569M |
| July 17, 2026 | 0.2569M |
| July 16, 2026 | 0.4889M |
| July 15, 2026 | 0.4889M |
| July 14, 2026 | 0.3895M |
| July 13, 2026 | 0.4226M |
| July 10, 2026 | 0.6546M |
| July 09, 2026 | 0.7209M |
| July 08, 2026 | 0.6878M |
| July 07, 2026 | 0.754M |
| July 06, 2026 | 0.5552M |
| July 02, 2026 | 0.3895M |
| July 01, 2026 | 0.4889M |
| June 30, 2026 | 0.3564M |
| June 29, 2026 | 0.4226M |
| June 26, 2026 | 0.3232M |
| June 25, 2026 | 0.2238M |
| June 24, 2026 | 0.3564M |
| June 23, 2026 | 0.1907M |
| June 22, 2026 | 0.1907M |
| June 18, 2026 | 0.1575M |
| June 17, 2026 | 0.1575M |
| June 16, 2026 | 0.1244M |
| June 15, 2026 | 0.2238M |
| June 12, 2026 | 0.2238M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| NervGen Pharma Corp. | 151.65M |
| Milestone Pharmaceuticals, Inc. | 100.70M |
| Clearmind Medicine, Inc. | -11.80M |
| Lexaria Bioscience Corp. | 13.49M |
| Target Group, Inc. (Canada) | 11.80M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.792M |
| Total Expenses (Quarterly) | 2.792M |
| EPS Diluted (Quarterly) | -0.7327 |
| Earnings Yield | -180.1% |
| Normalized Earnings Yield | -180.10 |